Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

33.51
-0.3600-1.06%
Post-market: 33.510.00000.00%17:54 EDT
Volume:1.50M
Turnover:50.45M
Market Cap:6.37B
PE:-11.64
High:34.29
Open:33.68
Low:33.21
Close:33.87
Loading ...
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 06, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Sep 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Sep 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 11, 2024

Major Issues Report

Form 8-K - Current report
Aug 21, 2024

Major Issues Report

Form 8-K - Current report
Aug 20, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Jul 23, 2024

Major Issues Report

Form 8-K - Current report
Jun 24, 2024

Major Issues Report

Form 8-K - Current report
Jun 06, 2024

Major Issues Report

Form 8-K - Current report
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 03, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2024

Major Issues Report

Form 8-K - Current report
Mar 06, 2024

Major Issues Report

Form 8-K - Current report
Mar 04, 2024

Major Issues Report

Form 8-K - Current report